Mephyton (Phytonadione) 5mg Tablets(2021-05-26)
- Starting date:
- May 26, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-75747
Last updated:
2021-06-05
Summary
-
Product:
Mephyton (Phytonadione) 5 mg Tablets
Reason
2-methyl-3 - ((E) -3,7,11,15-tetramethyl-hexadec-2-enyl) - [1,4] naphthoquinone impurity is out of specification in lot 19D012P. 2-methyl-3 - ((E) -3,7,11,15-tetramethyl-hexadec-2-enyl) - [1,4] naphthoquinone impurity is out of specification in lot 20D096P.
Depth of distribution
Healthcare Establishments
Affected products
Mephyton (Phytonadione) 5 mg Tablet
DIN, NPN, DIN-HIM
DIN N/A
Dosage form
Tablet
Strength
Phytonadione 5mg
Lot or serial number
19D012P, 20D096P
Companies
- Recalling Firm
-
Bausch Health Canada Inc
2150 Boulevard St-Elzéar
Laval
H7L 4A8
Quebec
CANADA
- Marketing Authorization Holder
-
N/A